DocuSign's Q1 Beat, Raised FY Outlook Fails To Impress Analysts

Shares of DocuSign Inc. (NASDAQ:DOCU) fell sharply on Friday despite the e-signature company’s better-than-expected first-quarter results, as investors focused on modest billings growth and a guidance increase that appeared largely driven by currency tailwinds rather than accelerating demand.

Key analyst takeaways:

• BTIG analyst Allan Verkhovski reiterated a Buy rating, while cutting the price target from $70 to $60.
• Needham analyst Scott Berg maintained a Hold rating on the stock.

Check out other analyst stock ratings.

BTIG: Although DocuSign reported its revenues $6 million higher than estimates, this was much lower than the average revenue beats of $15 million through fiscal 2026, Verkhovski said in a note. The company delivered current subscription billings growth of 4.6%, driven by currency benefits and only "modestly above" the 4.2% growth posted in each of the prior two first-quarter periods, he added.

CEO Allan Thygesen indicated early signs of recovery in the enterprise segment, including customers with ACV (annual contract value) of more than $300,000 growing to the double digits, supported by positive IAM adoption trends, the analyst stated. "We continue to believe DOCU will outperform its ARR guidance, which we estimate implies 17% growth (vs. 42% growth in FY26) in NNARR from expansion and new business, or excluding GRR improvements," he further wrote.

Needham: DocuSign reported a modest revenue upside in constant-currency terms, and its profit beat was driven by cost discipline, Berg said. He noted that:

• Revenue grew 8.7% year-on-year to $830.2 million, topping Needham's estimate of $824.2 million
• Non-GAAP earnings came at $1.09 per share, above Needham's estimate of $1.00 per share

Although management raised their fiscal 2027 revenue guidance to $3.490-$3.502 billion, or 8.6% growth at the mid-point, from their prior outlook of $3.484–$3.496 billion, or 8.4% growth, this incorporates currency benefits of around 1.3%, indicating that the guidance was "largely unchanged," the analyst stated.

He added, however, that DocuSign's "execution story" continues to improve, driving higher visibility into the company’s fiscal 2027 goal of accelerating ARR growth over the previous year's levels.

DOCU Price Action: Shares of DocuSign had declined by 6.77% to $47.49 at the time of publication on Friday.